Vaccine Development Pre-Clinical Testing Unit

The pre-clinical testing unit works to test efficacy, immunogenicity, and monitor long-term potency of candidate recombinant vaccines targeted at preventing neglected tropical diseases such as Hookworm, Schistosomiasis, Chagas disease, leishmaniasis, ascariasis, and trichuriasis.

The unit works closely with the Antigen Discovery, Formulation, and Quality Control within the Texas Children's Hospital Center for Vaccine Development as well as in collaboration with other institutions including The George Washington University, the National Institute of Allergy and Infectious Diseases, and the Autonomous University of Yucatán.

Laboratory Facilities

The unit shares laboratory collaborative laboratory space in Texas Children's Hospital Center for Vaccine Development.The unit also utilizes space at the Center for Comparative Medicine's Feigin Center and Taub Facilities located in the Texas Medical Center.

Our Team:

• Unit Director - Kathryn Jones, D.V.M., Ph.D.
• Research Coordinator - Brian Keegan